1000994-94-4

Basic information

• Product Name: 2-(4-(1,1-difluoroethyl)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane
• Synonyms: 2-(4-(1,1-difluoroethyl)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane;4-(1,1-Difluoroethyl)phenylboronic Acid Pinacol Ester;1,3,2-Dioxaborolane, 2-[4-(1,1-difluoroethyl)phenyl]-4,4,5,5-tetramethyl-
• CAS NO: 1000994-94-4
• Molecular Formula: C₁₄H₁₉BF₂O₂
• Molecular Weight: 286.1225464
• Mol File: 1000994-94-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-(4-(1,1-difluoroethyl)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(1,1-difluoroethyl)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane(1000994-94-4)
• EPA Substance Registry System: 2-(4-(1,1-difluoroethyl)phenyl)-4,4,5,5-tetraMethyl-1,3,2-dioxaborolane(1000994-94-4)

Safety Data

• Hazardous Substances Data: 1000994-94-4(Hazardous Substances Data)

Usage

Uses

1,3,2-Dioxaborolane, 2-[4-(1,1-difluoroethyl)phenyl]-4,4,5,5-tetramethyl-

Upstream product

• 1000994-95-5 1-bromo-4-(1,1-difluoroethyl)-benzene 
• 73183-34-3 bis(pinacol)diborane 
• 99-90-1 para-bromoacetophenone 

Relevant articles and documents

Scalable Approach to Fluorinated Heterocycles with Sulfur Tetrafluoride (SF4)

A general approach to fluorinated (hetero)aromatic derivatives is elaborated. The key reaction is a deoxofluorination of substituted acetophenones with sulfur tetrafluoride (SF4). In contrast to previous deoxofluorination methods, this transformation is fast, scalable (up to 70 g), and high-yielding. More than 100 novel or previously hardly accessible fluorinated heterocycles, interesting for medicinal chemistry and agrochemistry, were synthesized.

2-PYRIDONE COMPOUND

This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect and is useful as a p

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease, such as malaria, caused by a Plasmodium parasite.